[Jia Yueting: Investment in Qualigen Therapeutics Expected to Be Completed This Week] Foresight News reports that Faraday Future founder Jia Yueting stated in a tweet that Faraday Future's $30 million investment in Qualigen Therapeutics (QLGN) has more than doubled its market value. The strategic investment is expected to be completed next week (this week Beijing time). According to previous reports from Foresight News, Faraday Future announced a PIPE investment of approximately $41 million to acquire a stake in Qualigen Therapeutics, with plans to jointly develop crypto and Web3 businesses. After the transaction is completed, QLGN will be renamed CXC10, fully focusing on the crypto and Web3 ecosystem. Faraday Future and its founder Jia Yueting are expected to collectively hold over 62% of the shares, with Jia Yueting personally investing $4 million.